TY  - GEN
AU  - Hacke,W
AU  - Bluhmki,E
AU  - Steiner,T
AU  - Tatlisumak,T
AU  - Mahagne,M H
AU  - Sacchetti,M L
AU  - Meier,D
TI  - Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I
SN  - 0039-2499
PY  - 1998///1030
KW  - Cerebrovascular Disorders
KW  - drug therapy
KW  - Humans
KW  - National Institutes of Health (U.S.)
KW  - Outcome Assessment, Health Care
KW  - statistics & numerical data
KW  - Plasminogen Activators
KW  - therapeutic use
KW  - Recombinant Proteins
KW  - Retrospective Studies
KW  - Tissue Plasminogen Activator
KW  - United States
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1161/01.str.29.10.2073
ER  -